Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2026 Q1 | May 13, 2026 | Buckley Capital | -4.6% | -4.6% | ACHC, HGV, SEZL | Fintech, healthcare, small cap, special situations, turnaround, value | View | ||
| 2024 Q1 | Apr 15, 2024 | Aristotle Small Cap Equity Fund | 7.3% | 9.4% | ACHC, AER, ASC, ASGN, ATNI, AZEK, CPLP, DY, HURN, ITRI, MATW, MCRB, MMSI, MODV, MTSI, PWSC, QDEL, SP | Construction, healthcare, industrials, small caps, technology, value | Manager remains optimistic about long-term potential for small cap segment despite strong recent performance. Valuations of small versus large cap equities remain near multi-decade lows with 16.0x P/E for Russell 2000 versus 21.8x for Russell 1000. Small caps are better positioned to benefit from reshoring of U.S. manufacturing, CHIPS Act, and infrastructure projects. | PWSC QDEL MODV ITRI AZEK |
View |
| 2026 Q1 | Apr 13, 2026 | Greenlight Capital | 6.5% | 6.5% | ACHC, CNR, CROX, DHT, GPK, KD, SLM, VSNT | Geopolitical, gold, healthcare, Macro, oil, shipping, War | SLM CROX VSNT CNR DHT ACHC |
View | |
| 2025 Q4 | Feb 4, 2026 | Aristotle Small Cap Equity Fund | 1.9% | 0.2% | ACHC, AEIS, AER, ATR, AUB, CCRN, CNS, EHTH, GTLS, HAE, HURN, IDA, ITRI, LKQ, MTSI, NUS, PRGO, PTEN, TITN, WWW | Deregulation, Energy Transition, healthcare, M&A, Regional Banks, semiconductors, small caps, value | The fund focuses exclusively on small-cap equities with valuations remaining compelling relative to large caps, with the Russell 2000 Index trading near multi-decade lows on a relative basis. Potential tailwinds include deregulation, lower corporate tax rates, increased M&A activity, continued reshoring of U.S. manufacturing and infrastructure-related spending. Value stocks outperformed growth counterparts during the quarter as the Russell 2000 Value Index returned 3.26% compared to 1.22% for growth. Lower-quality companies outperformed higher-quality companies with factors like high bankruptcy risk, low sales growth, and low price to earnings having the strongest payoffs. MACOM Technology Solutions, a designer and manufacturer of high-performance semiconductor products, was a top contributor with strong quarterly results. The company has meaningful exposure to growing demand from Data Center and 5G end market applications along with domestic manufacturing footprint. Healthcare was the best-performing sector at +18.54% during the quarter. The fund holds positions in companies like Haemonetics in blood management and Acadia Healthcare in behavioral health services, though maintains an underweight allocation as it avoids biotechnology companies due to binary risk. The fund added positions in regional banks including Atlantic Union Bankshares and WesBanco, viewing DOGE-related concerns as creating attractive opportunities. These banks benefit from diversified customer bases, growing market share, and solid balance sheets positioned for trust and deposit opportunities. The fund holds positions in companies supporting power grid modernization through Itron's smart metering solutions and IDACORP's transmission opportunities. These companies are positioned to benefit from critical regional transmission opportunities and grid monitoring solutions. | View | |
| 2024 Q4 | Dec 31, 2024 | Wasatch Long/Short Alpha Fund | -8.3% | 7.2% | ACHC, ENSG, FND, GWRE, HLNE, HQY, ICFI, IONQ, KAI, MORN, NSA, PCTY, RBC, ROP | Beta, Defensive, Long/Short, Mid Caps, risk management, small caps | The Fund has shorted stocks of special purpose acquisition companies because their business models are speculative and their paths to steady compounded earnings growth remain unclear. These stocks experienced sharp gains during the risk-on environment of the quarter. | IONQ ACHC FND ICFI HQY PCTY |
View |
| 2024 Q3 | Sep 30, 2024 | Aristotle Small Cap Equity Fund | 7.3% | 9.4% | ACHC, ACIW, AER, ASC, BDC, BWIN, CHCT, DY, FIBK, HURN, ITRI, LUMN, MDVL, MMSI, MRCY, MTSI, NVRI, PETQ, PTEN | financials, healthcare, rates, small caps, technology, value | The fund focuses exclusively on small-cap investments with valuations remaining attractive relative to large caps. Small caps trade at 16.7x P/E versus 25.8x for large caps, near multi-decade lows. The manager believes small caps are better positioned to benefit from reshoring, M&A activity, and infrastructure spending. | View | |
| 2022 Q3 | Sep 30, 2022 | Aristotle Small Cap Equity Fund | 7.3% | 9.4% | ACHC, CCRN, MRCY, PETQ | - | View | ||
| 2022 Q4 | Jan 31, 2023 | Meridian Contrarian Fund | 6.9% | 0.0% | ACHC, BEPC, CARS, DBRG, TTC, VWE | - | View | ||
| 2024 Q4 | Jan 23, 2025 | Aristotle Small Cap Equity Fund | -0.5% | 9.4% | ACHC, AMTM, ASC, AXTA, AZPN, COLD, DY, EMR, GTLS, HASI, HURN, HXL, INFN, J, KBH, LQDT, MTSI, NOK, SUM, TROX | healthcare, industrials, M&A, materials, small caps, technology, value | Manager remains optimistic about long-term potential for small-cap segment. Valuations within small-cap segment remain compelling relative to large caps, with Russell 2000 Index trading near multi-decade lows on a relative basis. Potential tailwinds include deregulation, increased M&A activity, continued decline in interest rates, continued reshoring of U.S. manufacturing, and infrastructure-related spending. | TROX HXL AXTA COLD AMTM ASC ACHC GTLS |
View |
| 2024 Q4 | Jan 23, 2025 | Aristotle Small/Mid Cap Equity | -0.5% | 13.5% | ACHC, AXTA, AZPN, CMCO, COLD, CTLT, DOC, GTLS, HXL, INFN, NSIT, SUM | growth, healthcare, industrials, materials, SMID Cap, technology, value | Chart Industries benefited from surging demand for cryogenic equipment used in the clean energy sector, with record high orders and substantial sales increases. The company's equipment serves the industrial gas, energy, and biomedical industries with particular strength in clean energy applications. | NSIT HXL DOC CMCO AXTA COLD |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Fund Letters | Greenlight Capital | Acadia Healthcare | Medical Care Facilities | Health Care Facilities | Bull | NASDAQ | Behavioral Healthcare, Distressed, Healthcare Facilities, Management Change, turnaround, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | Aristotle Small Cap Equity Fund | Acadia Healthcare | Health Care | Health Care Services | Bull | NASDAQ | Behavioral Healthcare, contrarian, Healthcare services, Mental health, regulatory scrutiny, Substance Abuse Treatment | View Pitch |
| Apr 13, 2026 | Fund Letters | Wasatch Long/Short Alpha Fund | Acadia Healthcare Company, Inc. | Health Care | Health Care Facilities | Bear | NASDAQ | Bear, Behavioral health, Business Model Deterioration, Government Investigation, Healthcare Facilities, Regulatory risk, Short Position | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Steven A. Cohen | Point72 Asset Management | $86.8B | $411,510 | 0.00% | 29,000 | +29,000 | +100.00% | 0.0272% |
| Lee Ainslie | Maverick Capital | $9.3B | $12.8M | 0.14% | 905,419 | -2,101,086 | -69.88% | 0.8488% |
| Mark Bussard | Rock Springs Capital | $1.9B | $1.7M | 0.09% | 120,000 | -50,000 | -29.41% | 0.1125% |
| Ray Dalio | Bridgewater Associates | $27.4B | $2.4M | 0.01% | 171,288 | +80,310 | +88.27% | 0.1606% |
| Israel Englander | Millennium Management LLC | $233.2B | $709,500 | 0.00% | 50,000 | +180,787 | +73.04% | 0.0469% |
| Aaron Weitman | CastleKnight Management LP | $4.5B | $1.4M | 0.03% | 98,800 | -295,200 | -74.92% | 0.0926% |
| David Siegel & John Overdeck | Two Sigma Investments | $67.5B | $10.4M | 0.02% | 735,859 | +594,677 | +421.21% | 0.6899% |
| Cliff Asness | AQR Capital Management | $190.6B | $3.9M | 0.00% | 272,670 | +114,868 | +72.79% | 0.2556% |
| James E. Flynn | Deerfield Management | $6.9B | $64.1M | 0.93% | 4,520,000 | +3,331,000 | +280.15% | 4.2375% |
| Louis Bacon | Moore Capital Management | $6.8B | $786,069 | 0.01% | 55,396 | +55,396 | +100.00% | 0.0519% |
| Rich Handler | Jefferies | $19.3B | $48.0M | 0.25% | 3,379,813 | +3,370,437 | +35947.49% | 3.1686% |